Denali Therapeutics Inc.
US ˙ NasdaqGS ˙ US24823R1059

SecurityDNLI / Denali Therapeutics Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership181,417 shares
Latest Disclosed Value $ 3,483,207
Citadel Advisors Llc ownership in DNLI / Denali Therapeutics Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 181,417 shares of Denali Therapeutics Inc. (US:DNLI) valued at $3,483,206 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 779,148 shares of Denali Therapeutics Inc.. This represents a change in shares of -76.72% during the quarter. The current value of the position is $3,566,658 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (DNLI) in the form of stock options. The firm currently holds call options representing 40,300 of underlying shares valued at $773,760 USD and put options representing 129,300 of underlying shares valued at $2,482,560 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DNLI / Denali Therapeutics Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F DENALI THERAPEUTICS COM 24823R105 181,417 -597,731 -76.72 3,483 -72.92 0.0005
2026-02-17 2025-12-31 13F DENALI THERAPEUTICS COM 24823R105 779,148 90,924 13.21 12,864 28.72 0.0019
2025-11-14 2025-09-30 13F DENALI THERAPEUTICS COM 24823R105 688,224 -560,729 -44.90 9,993 -42.81 0.0015
2025-08-14 2025-06-30 13F DENALI THERAPEUTICS COM 24823R105 1,248,953 79,270 6.78 17,473 9.88 0.0030
2025-05-15 2025-03-31 13F DENALI THERAPEUTICS COM 24823R105 1,169,683 339,772 40.94 15,902 -5.98 0.0030
2025-02-14 2024-12-31 13F DENALI THERAPEUTICS COM 24823R105 829,911 52,631 6.77 16,914 -25.30 0.0029
2024-11-14 2024-09-30 13F DENALI THERAPEUTICS COM 24823R105 777,280 -441,418 -36.22 22,642 -19.99 0.0044
2024-08-14 2024-06-30 13F DENALI THERAPEUTICS COM 24823R105 1,218,698 -146,330 -10.72 28,298 1.03 0.0057
2024-05-15 2024-03-31 13F DENALI THERAPEUTICS COM 24823R105 1,365,028 1,296,918 1,904.15 28,010 1,817.18 0.0054
2024-02-14 2023-12-31 13F DENALI THERAPEUTICS COM 24823R105 68,110 6,205 10.02 1,462 14.41 0.0003
2023-11-14 2023-09-30 13F DENALI THERAPEUTICS COM 24823R105 61,905 5,802 10.34 1,277 -22.84 0.0003
2023-08-14 2023-06-30 13F DENALI THERAPEUTICS COM 24823R105 56,103 -1,318,222 -95.92 1,656 -94.77 0.0003
2023-05-15 2023-03-31 13F DENALI THERAPEUTICS COM 24823R105 1,374,325 1,339,712 3,870.55 31,664 3,191.48 0.0070
2023-02-14 2022-12-31 13F DENALI THERAPEUTICS COM 24823R105 34,613 -28,924 -45.52 963 -50.67 0.0002
2022-11-14 2022-09-30 13F DENALI THERAPEUTICS COM 24823R105 63,537 -242,465 -79.24 1,950 -78.35 0.0004
2022-08-15 2022-06-30 13F DENALI THERAPEUTICS COM 24823R105 306,002 -445,601 -59.29 9,006 -62.75 0.0023
2022-05-16 2022-03-31 13F DENALI THERAPEUTICS COM 24823R105 751,603 265,920 54.75 24,179 11.62 0.0050
2022-02-14 2021-12-31 13F DENALI THERAPEUTICS COM 24823R105 485,683 422,672 670.79 21,662 581.41 0.0044
2021-11-15 2021-09-30 13F DENALI THERAPEUTICS Cmn 24823R105 63,011 63,011 3,179 0.0007
2021-08-16 2021-06-30 13F DENALI THERAPEUTICS COM 24823R105 0 -240,784 -100.00 0 -100.00
2021-05-21 2021-03-31 13F/A-1 DENALI THERAPEUTICS COM 24823R105 240,784 235,671 4,609.25 13,749 3,112.38 0.0034
2021-05-17 2021-03-31 13F DENALI THERAPEUTICS COM 24823R105 240,784 235,671 13,749 0.0034
2021-02-16 2020-12-31 13F DENALI THERAPEUTICS COM 24823R105 5,113 -213,024 -97.66 428 -94.52 0.0001
2020-11-16 2020-09-30 13F DENALI THERAPEUTICS COM 24823R105 218,137 107,572 97.29 7,816 192.41 0.0022
2020-08-14 2020-06-30 13F DENALI THERAPEUTICS Cmn 24823R105 110,565 38,213 52.82 2,673 110.97 0.0010
2020-05-15 2020-03-31 13F DENALI THERAPEUTICS Cmn 24823R105 72,352 18,766 35.02 1,267 35.80 0.0006
2020-02-14 2019-12-31 13F DENALI THERAPEUTICS Cmn 24823R105 53,586 -34,823 -39.39 933 -31.09 0.0004
2019-11-14 2019-09-30 13F DENALI THERAPEUTICS Cmn 24823R105 88,409 -106,467 -54.63 1,354 -66.53 0.0006
2019-08-14 2019-06-30 13F DENALI THERAPEUTICS Cmn 24823R105 194,876 167,111 601.88 4,045 527.13 0.0019
2019-05-15 2019-03-31 13F DENALI THERAPEUTICS Cmn 24823R105 27,765 27,765 645 0.0003
2018-11-13 2018-09-30 13F DENALI THERAPEUTICS Cmn 24823R105 0 -49,421 -100.00 0 -100.00
2018-08-14 2018-06-30 13F/A-1 DENALI THERAPEUTICS Cmn 24823R105 49,421 49,421 753 0.0004
2018-08-10 2018-06-30 13F DENALI THERAPEUTICS Cmn 24823R105 49,421 753 0.0004
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F DENALI THERAPEUTICS COM Call 40,300 48.71 774 72.93 n/a n/a n/a
2026-02-17 2025-12-31 13F DENALI THERAPEUTICS COM Call 27,100 133.62 447 166.07 n/a n/a n/a
2025-11-14 2025-09-30 13F DENALI THERAPEUTICS COM Call 11,600 -43.14 168 -41.05 n/a n/a n/a
2025-08-14 2025-06-30 13F DENALI THERAPEUTICS COM Call 20,400 0.00 285 2.89 n/a n/a n/a
2025-05-15 2025-03-31 13F DENALI THERAPEUTICS COM Call 20,400 5.15 277 -29.87 n/a n/a n/a
2025-02-14 2024-12-31 13F DENALI THERAPEUTICS COM Call 19,400 34.72 395 -5.73 n/a n/a n/a
2024-11-14 2024-09-30 13F DENALI THERAPEUTICS COM Call 14,400 -7.10 419 16.71 n/a n/a n/a
2024-08-14 2024-06-30 13F DENALI THERAPEUTICS COM Call 15,500 -18.42 360 -7.71 n/a n/a n/a
2024-05-15 2024-03-31 13F DENALI THERAPEUTICS COM Call 19,000 187.88 390 175.89 n/a n/a n/a
2024-02-14 2023-12-31 13F DENALI THERAPEUTICS COM Call 6,600 -37.74 142 -35.32 n/a n/a n/a
2023-11-14 2023-09-30 13F DENALI THERAPEUTICS COM Call 10,600 -0.93 219 -30.79 n/a n/a n/a
2023-08-14 2023-06-30 13F DENALI THERAPEUTICS COM Call 10,700 -52.23 316 -38.95 n/a n/a n/a
2023-05-15 2023-03-31 13F DENALI THERAPEUTICS COM Call 22,400 -12.50 516 -27.43 n/a n/a n/a
2023-02-14 2022-12-31 13F DENALI THERAPEUTICS COM Call 25,600 71.81 712 55.58 n/a n/a n/a
2022-11-14 2022-09-30 13F DENALI THERAPEUTICS COM Call 14,900 -22.80 457 -19.54 n/a n/a n/a
2022-08-15 2022-06-30 13F DENALI THERAPEUTICS COM Call 19,300 101.04 568 83.82 n/a n/a n/a
2022-05-16 2022-03-31 13F DENALI THERAPEUTICS COM Call 9,600 -29.93 309 -49.43 n/a n/a n/a
2022-02-14 2021-12-31 13F DENALI THERAPEUTICS COM Call 13,700 -37.16 611 -44.45 n/a n/a n/a
2021-11-15 2021-09-30 13F DENALI THERAPEUTICS Cmn Call 21,800 21.79 1,100 -21.65 n/a n/a n/a
2021-08-16 2021-06-30 13F DENALI THERAPEUTICS COM Call 17,900 3.47 1,404 42.11 n/a n/a n/a
2021-05-21 2021-03-31 13F/A DENALI THERAPEUTICS COM Call 17,300 -48.66 988 -65.00 n/a n/a n/a
2021-05-17 2021-03-31 13F DENALI THERAPEUTICS COM Call 17,300 988 n/a n/a n/a
2021-02-16 2020-12-31 13F DENALI THERAPEUTICS COM Call 33,700 132.41 2,823 442.88 n/a n/a n/a
2020-11-16 2020-09-30 13F DENALI THERAPEUTICS COM Call 14,500 520 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F DENALI THERAPEUTICS COM Put 129,300 2,483 n/a n/a n/a
2025-11-14 2025-09-30 13F DENALI THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F DENALI THERAPEUTICS COM Put 15,400 94.94 215 100.93 n/a n/a n/a
2025-05-15 2025-03-31 13F DENALI THERAPEUTICS COM Put 7,900 16.18 107 -22.46 n/a n/a n/a
2025-02-14 2024-12-31 13F DENALI THERAPEUTICS COM Put 6,800 44.68 139 1.47 n/a n/a n/a
2024-11-14 2024-09-30 13F DENALI THERAPEUTICS COM Put 4,700 -43.37 137 -29.17 n/a n/a n/a
2024-08-14 2024-06-30 13F DENALI THERAPEUTICS COM Put 8,300 -20.95 193 -10.70 n/a n/a n/a
2024-05-15 2024-03-31 13F DENALI THERAPEUTICS COM Put 10,500 320.00 215 305.66 n/a n/a n/a
2024-02-14 2023-12-31 13F DENALI THERAPEUTICS COM Put 2,500 -30.56 54 -28.38 n/a n/a n/a
2023-11-14 2023-09-30 13F DENALI THERAPEUTICS COM Put 3,600 500.00 74 335.29 n/a n/a n/a
2023-08-14 2023-06-30 13F DENALI THERAPEUTICS COM Put 600 -95.00 18 -93.84 n/a n/a n/a
2023-05-15 2023-03-31 13F DENALI THERAPEUTICS COM Put 12,000 33.33 276 10.40 n/a n/a n/a
2023-02-14 2022-12-31 13F DENALI THERAPEUTICS COM Put 9,000 11.11 250 0.40 n/a n/a n/a
2022-11-14 2022-09-30 13F DENALI THERAPEUTICS COM Put 8,100 14.08 249 19.14 n/a n/a n/a
2022-08-15 2022-06-30 13F DENALI THERAPEUTICS COM Put 7,100 209 n/a n/a n/a
2022-05-16 2022-03-31 13F DENALI THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-14 2021-12-31 13F DENALI THERAPEUTICS COM Put 38,900 105.82 1,735 81.87 n/a n/a n/a
2021-11-15 2021-09-30 13F DENALI THERAPEUTICS Cmn Put 18,900 23.53 954 -20.50 n/a n/a n/a
2021-08-16 2021-06-30 13F DENALI THERAPEUTICS COM Put 15,300 -15.00 1,200 16.73 n/a n/a n/a
2021-05-21 2021-03-31 13F/A DENALI THERAPEUTICS COM Put 18,000 25.87 1,028 -14.19 n/a n/a n/a
2021-05-17 2021-03-31 13F DENALI THERAPEUTICS COM Put 18,000 1,028 n/a n/a n/a
2021-02-16 2020-12-31 13F DENALI THERAPEUTICS COM Put 14,300 107.25 1,198 385.02 n/a n/a n/a
2020-11-16 2020-09-30 13F DENALI THERAPEUTICS COM Put 6,900 247 n/a n/a n/a
2020-08-14 2020-06-30 13F DENALI THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F DENALI THERAPEUTICS Cmn Put 12,300 -6.82 215 -6.52 n/a n/a n/a
2020-02-14 2019-12-31 13F DENALI THERAPEUTICS Cmn Put 13,200 17.86 230 33.72 n/a n/a n/a
2019-11-14 2019-09-30 13F DENALI THERAPEUTICS Cmn Put 11,200 172 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.